Cargando…
Long-Term Clinical Outcomes of Invasive Giant Prolactinomas after a Mean Ten-Year Followup
Objective. The aim of this study is to observe clinical outcomes after more than ten years of followup in a group of patients with invasive giant prolactinomas (IGPs) treated with dopamine agonists (DAs). Methods. Twenty-five patients met the criteria of IGPs, among which 16 patients primarily recei...
Autores principales: | Wu, Ze Rui, Zhang, Yong, Cai, Lin, Lin, Shao Jian, Su, Zhi Peng, Wei, Yong Xu, Shang, Han Bing, Yang, Wen Lei, Zhao, Wei Guo, Wu, Zhe Bao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5141542/ https://www.ncbi.nlm.nih.gov/pubmed/27999593 http://dx.doi.org/10.1155/2016/8580750 |
Ejemplares similares
-
Cabergoline Treatment in Invasive Giant Prolactinoma
por: Alsubaie, Sadeem, et al.
Publicado: (2014) -
Lost to Follow-Up: Complications of an Invasive Giant Prolactinoma
por: Blackmon, Melodie M, et al.
Publicado: (2020) -
Mean platelet volume in patients with prolactinoma
por: Tam, Abbas Ali, et al.
Publicado: (2015) -
Efficacy and Safety of Cabergoline as First Line Treatment for Invasive Giant Prolactinoma
por: Cho, Eun-Hee, et al.
Publicado: (2009) -
Temozolomide: Anti-tumor effect on giant, invasive and resistant pediatric prolactinoma
por: Chentli, Farida, et al.
Publicado: (2013)